Not rated Dealerships need five reviews in the past 24 months before we can display a rating. (14 reviews) 2030 Great Deals out of 8403 listings 2209 Great Deals out of 9045 listings 1999 Great Deals ...
Moderna has shared some of the phase 1/2 data that persuaded it to expand and prioritize development of a cancer candidate, reporting responses in melanoma patients failed by checkpoint inhibitors.
Regeneron has posted updated clinical data on DB-OTO, providing more evidence of the gene therapy’s potential to treat a rare genetic form of deafness as it plans for a potential FDA filing later this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback